Parallel Advisors »

Kalaris Therapeutics shares owned by Parallel Advisors

Quarter-by-quarter ownership of Kalaris Therapeutics (KLRS) shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in Kalaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kalaris Therapeutics held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalaris Therapeutics by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $282 49 5.78
2025-06-30 $131 49 2.67
2025-03-31 $392 49 8.02

More positions owned by Parallel Advisors

Ishares S&p 500 Index Etf (IVV)
Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Corcept Therapeutics Stock (CORT)
Apple Stock (AAPL)
Nvidia Corp Stock (NVDA)
Microsoft Stock (MSFT)
Ishares U.s. Equity Factor Rotation Active Etf Etf (DYNF)
Amazon.com Stock (AMZN)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Google Stock (GOOGL)
Cvb Finl Corp Stock (CVBF)
Vanguard Large Cap Etf (VV)
Janus Henderson Mortgage-backed Securities Etf Etf (JMBS)
Ishares Core Msci Eafe Etf Etf (IEFA)
Avantis International Equity Etf Etf (AVDE)

View all positions for Parallel Advisors

Top funds holding Kalaris Therapeutics

Samsara BioCapital
Tang Capital Management
Siren
Woodline Partners
Vanguard Group
Renaissance Technologies
Redmile Group
Geode Capital Management
BlackRock
Squarepoint Ops
Fortis Capital Advisors
Belpointe Asset Management
Millennium Management
State Street Corporation
Bridgeway Capital Management

View all funds holding Kalaris Therapeutics